These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32429048)

  • 1. Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor.
    Liu WC; Shyu JF; Lim PS; Fang TC; Lu CL; Zheng CM; Hou YC; Wu CC; Lin YF; Lu KC
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
    Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway.
    Eisa NH; Reddy SV; Elmansi AM; Kondrikova G; Kondrikov D; Shi XM; Novince CM; Hamrick MW; McGee-Lawrence ME; Isales CM; Fulzele S; Hill WD
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function.
    Park R; Madhavaram S; Ji JD
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Human Osteoclast Differentiation by Kynurenine through the Aryl-Hydrocarbon Receptor Pathway.
    Kim SY; Oh Y; Jo S; Ji JD; Kim TH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis.
    Izawa T; Arakaki R; Mori H; Tsunematsu T; Kudo Y; Tanaka E; Ishimaru N
    J Immunol; 2016 Dec; 197(12):4639-4650. PubMed ID: 27849171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis.
    Lee HI; Lee GR; Lee J; Kim N; Kwon M; Kim HJ; Kim NY; Park JH; Jeong W
    BMB Rep; 2020 Apr; 53(4):218-222. PubMed ID: 31964469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
    Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
    J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells.
    Lano G; Laforêt M; Von Kotze C; Perrin J; Addi T; Brunet P; Poitevin S; Burtey S; Dou L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoxyl Sulfate Inhibits Osteogenesis in Bone Marrow Mesenchymal Stem Cells through the AhR/Hes1 Pathway.
    Hsieh CW; Chang LH; Wang YH; Li WT; Chang JK; Chen CH; Ho ML
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
    Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Coumarin Derivative 5'-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways.
    Abdallah BM; Ali EM; Elsawy H; Badr GM; Abdel-Moneim AM; Alzahrani AM
    Biomed Res Int; 2019; 2019():9395146. PubMed ID: 31976330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
    Omi M; Kaartinen V; Mishina Y
    J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade.
    Yeon JT; Kim KJ; Son YJ; Park SJ; Kim SH
    Arch Pharm Res; 2019 Aug; 42(8):712-721. PubMed ID: 31161369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW 264.7 cells.
    Xu H; Liu T; Li J; Xu J; Chen F; Hu L; Zhang B; Zi C; Wang X; Sheng J
    Biomed Pharmacother; 2019 Oct; 118():109237. PubMed ID: 31376653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat.
    Lee KY; Kim JH; Kim EY; Yeom M; Jung HS; Sohn Y
    BMC Complement Altern Med; 2019 Aug; 19(1):207. PubMed ID: 31399090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl Acetate Fraction of Aqueous Extract of Lentinula edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression.
    Lee H; Lee K; Lee S; Lee J; Jeong WT; Lim HB; Hyun TK; Yi SJ; Kim K
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.